Literature DB >> 1237240

The development of the circulating blood volume of the chick embryo.

C Kind.   

Abstract

The circulating blood volume of the chick embryo was determined from the 4th up to the 18th day of hatching. In contrast to former studies, there was employed a radioisotope dilution method with albumin-bound I131. The findings are in close correspondence to those of the earlier studies. The blood volume does not display an entirely perfect curve of exponential growth, i.e., the doubling time increases steadily. The blood volume attains a peak value between the 16th and 18th day and decreases somewhat toward the end of the hatching period. There has been postulated a reduction of total red cell volume and hemoglobin caused by the involution of the extraembryonic circulatory system. The destruction of the erythrocytes seems to take place in the endodermal epithelium of the proximal yolk sac, where an accumulation of iron could be demonstrated on the 19th and 20th days.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1237240     DOI: 10.1007/bf00306727

Source DB:  PubMed          Journal:  Anat Embryol (Berl)        ISSN: 0340-2061


  2 in total

1.  Blood volume and red cell concentration in the normal chick embryo.

Authors:  A E BARNES; W N JENSEN
Journal:  Am J Physiol       Date:  1959-08

2.  Estimation of the blood volumes of embryonated hen eggs at different ages.

Authors:  Y YOSPHE-PURER; J FENDRICH; A M DAVIES
Journal:  Am J Physiol       Date:  1953-11
  2 in total
  10 in total

1.  Plasma testosterone concentration in control and testosterone-treated chick embryos.

Authors:  J M Gasc; M Thibier
Journal:  Experientia       Date:  1979-10-15

2.  In Vivo Confocal Imaging of Fluorescently Labeled Microbubbles: Implications for Ultrasound Localization Microscopy.

Authors:  Matthew R Lowerison; Chengwu Huang; Yohan Kim; Fabrice Lucien; Shigao Chen; Pengfei Song
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2020-04-15       Impact factor: 2.725

3.  Kalman Filter-Based Microbubble Tracking for Robust Super-Resolution Ultrasound Microvessel Imaging.

Authors:  Shanshan Tang; Pengfei Song; Joshua D Trzasko; Matthew Lowerison; Chengwu Huang; Ping Gong; U-Wai Lok; Armando Manduca; Shigao Chen
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2020-03-31       Impact factor: 2.725

4.  Sensitivity of cancer cells to truncated diphtheria toxin.

Authors:  Yi Zhang; Wendy Schulte; Desmond Pink; Kyle Phipps; Andries Zijlstra; John D Lewis; David Morton Waisman
Journal:  PLoS One       Date:  2010-05-05       Impact factor: 3.240

5.  Mutant PIK3CA controls DUSP1-dependent ERK 1/2 activity to confer response to AKT target therapy.

Authors:  A Sathe; F Guerth; M V Cronauer; M M Heck; M Thalgott; J E Gschwend; M Retz; R Nawroth
Journal:  Br J Cancer       Date:  2014-11-04       Impact factor: 7.640

6.  Two key cathepsins, TgCPB and TgCPL, are targeted by the vinyl sulfone inhibitor K11777 in in vitro and in vivo models of toxoplasmosis.

Authors:  Juan D Chaparro; Timmy Cheng; Uyen Phuong Tran; Rosa M Andrade; Sara B T Brenner; Grace Hwang; Shara Cohn; Ken Hirata; James H McKerrow; Sharon L Reed
Journal:  PLoS One       Date:  2018-03-22       Impact factor: 3.240

7.  The CAM cancer xenograft as a model for initial evaluation of MR labelled compounds.

Authors:  Zhi Zuo; Tatiana Syrovets; Yuzhou Wu; Susanne Hafner; Ina Vernikouskaya; Weina Liu; Genshan Ma; Tanja Weil; Thomas Simmet; Volker Rasche
Journal:  Sci Rep       Date:  2017-05-03       Impact factor: 4.379

8.  Egg-in-cube: design and fabrication of a novel artificial eggshell with functionalized surface.

Authors:  Wenjing Huang; Fumihito Arai; Tomohiro Kawahara
Journal:  PLoS One       Date:  2015-03-13       Impact factor: 3.240

9.  Low-power photodynamic therapy induces survival signaling in perihilar cholangiocarcinoma cells.

Authors:  Ruud Weijer; Mans Broekgaarden; Rowan F van Golen; Esther Bulle; Esther Nieuwenhuis; Aldo Jongejan; Perry D Moerland; Antoine H C van Kampen; Thomas M van Gulik; Michal Heger
Journal:  BMC Cancer       Date:  2015-12-26       Impact factor: 4.430

10.  Antitumor and antiangiogenic activity of the novel chimeric inhibitor animacroxam in testicular germ cell cancer.

Authors:  Gustav Steinemann; Alexandra Dittmer; Jacob Schmidt; David Josuttis; Michael Fähling; Bernhard Biersack; Nicola Beindorff; Eva Jolante Koziolek; Rainer Schobert; Winfried Brenner; Thomas Müller; Bianca Nitzsche; Michael Höpfner
Journal:  Mol Oncol       Date:  2019-10-22       Impact factor: 6.603

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.